OT:"Have you looked at AT before?"
I am convinced that the AT niche which uses its data base for medical diagnosis is the only high priest
authority for cancer patients with challenging survival needs.
No single doctor can keep up with the 8K studies per day ( no typing error), and this
factor appears to have lead and made necessary the latest press of the button summary by the formidable AT entity and its retrievable data ( having feed into its system every cancer study)to be ahead of a genius doctor's up loads (to his brain) of possible treatments by 18-24 months. And so far, the AT picks up 30% ( as recently reported) more possible ingenuities for the challenged beleaguered cancer patient for which a consensus of a panel of top MD's would not at that time notice.
I gather that once critical mass is positioned like Watson, once IBM threw in 14 billion, the top AT firm takes all.
I know nothing about AT for driving, and probably will know more soon as have a friend entering the business as a discovery type, and personally curious what the smaller AT start ups are working on,
and what type of cash burn is needed at that level to generate profitable revenues.